Management of Diabetes With Metformin In Patients With Chronic Heart Failure

Completed · Not applicable

Conditions studied: Heart Failure, Diabetes

In brief

The Ahmanson-UCLA Cardiomyopathy Center is conducting a clinical research study that will assess the use of the medication metformin to improve quality of life, exercise capacity, and improved outcomes with patients that have both heart failure and diabetes. If you participate in this study, you will receive the drug metformin for approximately 3 months. During the study you will undergo comprehensive testing which includes blood draws, an echocardiogram, and an magnetic resonance imaging (MRI)(if you do not have a pacemaker or defibrillator). You will also fill out a questionnaire and keep a blood glucose log. You must be 18 years old to participate. The study drugs, study follow-up visits, and laboratory tests will be provided free of charge. Participants will be reimbursed up to $200 for their time and travel expenses.

Key facts

Study ID

NCT01122316

Run by

University of California, Los Angeles

People needed

10

Starts

2009-09-01

Expected to finish

2012-01-01

Last updated by the study team

2020-09-04

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Systolic HF of any etiology (left ventricular ejection fraction ≤ 40%)
• Previously-diagnosed, inadequately controlled DM (HbA1c≥7.5%)
• On any combination of anti-diabetic medications excluding metformin

You may not qualify if…

• Current metformin therapy
• Previous intolerance to metformin therapy
• Renal dysfunction (creatinine clearance < 60 ml/minute)
• History of lactic acidosis.

Where it is running

• Ahmanson-UCLA Cardiomyopathy Center — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.